Artal Group S.A. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$3,390,000
-7.5%
405,0000.0%0.13%
-10.9%
Q3 2019$3,665,000
-16.0%
405,0000.0%0.15%
-16.5%
Q2 2019$4,362,000
+14.3%
405,000
+1.2%
0.18%
+12.8%
Q1 2019$3,816,000
-16.9%
400,0000.0%0.16%
-8.2%
Q4 2018$4,592,000
-9.7%
400,000
+33.3%
0.17%
+28.8%
Q3 2018$5,085,000
+79.0%
300,000
+50.0%
0.13%
+120.0%
Q2 2018$2,840,000
-0.4%
200,000
+33.3%
0.06%
+66.7%
Q1 2018$2,850,000150,0000.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders